Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C91758
http://purl.obolibrary.org/obo/NCIT_C91758
|
|---|---|
| Preferred Name | Asulacrine |
| Definitions |
An amsacrine analogue with antineoplastic properties. Asulacrine inhibits the enzyme topoisomerase ll, thereby blocking DNA replication and RNA and protein synthesis.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | An amsacrine analogue with antineoplastic properties. Asulacrine inhibits the enzyme topoisomerase ll, thereby blocking DNA replication and RNA and protein synthesis. |
|---|---|
| prefLabel | Asulacrine
|
| label | Asulacrine
|
| Has_Salt_Form | |
| code | C91758
|
| prefixIRI | NCIT:C91758
|
| in_subset | |
| Preferred_Name | Asulacrine
|
| FDA_UNII_Code | S8P50T62B6
|
| Contributing_Source | FDA
|
| Chemical_Formula | C24H24N4O4S
|
| Maps_To | Asulacrine
|
| CAS_Registry | 80841-47-0
|
| NSC Number | 343499
|
| Legacy Concept Name | CI-921
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
|
| UMLS_CUI | C1765331
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |